1Newburger JW, Takahashi M, Gerber MA, el al. Diagnosis, treat- ment, and long term management of Kawasaki disease: a stale- ment for health professionals from committee an rheumatic fe- ver, endocarditis, and Kawasaki disease, eouncil on cardiovascu- lar disease in the young, American Heart Association [J]. Pedi- atrics, 2004,114 : 1708-1733.
2Wu-Wong JR. Endothelial dysfunction and chronic kidney dis- ease: treatment options [J]. Curr opin Investing Drugs, 2008,9 (9) :970-982.
3Okada K, Hara J, Maki I, et al. Pulse methylprednisotone with gammaglobulin as an initial treatment for acute Kawasaki dis- ease [J]. EurJ Pediatr,2009,168(2): 181-185.
4Sittiwangkul R, Pongprot Y, Silvilairat S, et al. Management and outcome of intravenous gammaglobulin-resistant Kawasaki dis- ease [J ]. Singapore Med J, 2006,47 (9) : 780-784.
5Sang L, Yong P, Jung S, et al. The mid-range of the adjusted lev- el of ferritin can predict the chronic course in patients with adult onset still's disease [ J ]. J Rheumatol, 2009,36 : 3899-3902.
6Tumiati B, Casoli P, Perazzoli F, et al. Neerotizing Lymphadeni- tis in Systemic Lupus Erythematosus Kikuchi' s Disease or a Ki- kuchi' s-Like Disease? [J]. J Clin Rheumatol, 1999, 5 (3) : 121-125.
3Ohga S,Ooshima A,Fukushige J,et al.Histiocytic haemophagocytosis in a patient with Kawasadi disease:change in the hypercytic syndrome.Eur J Pediatr,1995,154:539-541.
4Kaneko K,Takahashi K,Fujiwara S,et al.Kawasaki disease followed by hemophagocytic syndrome.Acta Pediatr,1998,610-611.
6Muise A,Tallett SE,Silverman ED.Are children with Kawasaki disease and prolonged fever at risk for macrophage activation syndrome? Pediatrics,2003,112:e495-e497.
7Avcin T,Schneider R,Silverman ED,et al.Macrophage activation syndrome as the presenting manifestation of rheumatic diseases in childhood.J Pediatr,2006,148:683-686.
